GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Based on Intelligencia AI’s comprehensive, proprietary database of over 20,000 industry-sponsored, interventional oncology clinical programs (around 12,400 clinical trials), recent insights highlight ...

By Karen Roman Biopharmaceutical company ReAlta Life Sciences said it designated immunologist Laurie Glimcher, M.D., to its ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

TriSalus Life Sciences expects 50% sales growth and EBITDA positivity in 2025. See why TLSI stock could benefit, with key ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Adolescence is a critical period for the development of risky behaviors, like alcohol and drug use, reckless driving, and ...

In this week’s edition of the biotech bi-weekly, learn more about Thermo Fisher’s new system for automating complex sample ...